Antibodies Market 2027 By Type, Technology, Application, End-User | The Insight Partners

Antibodies Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Monoclonal Antibodies, Polyclonal Antibodies, ADCs, Others); Technology (Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Others); Application (into Proteomics, Drug Development, Genomics); End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes,, CROs)

Report Code: TIPRE00005787 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid

MARKET INTRODUCTION

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. When an interloper enters the body, the immune system springs into action. Antibodies find an antigen, stick to it, and recognize for the immune system the exact type of antigen so that an antibody can destroy it. Each antibody made for one and only one antigen, and it's fitted with special receptors that will only bind to that antigen.

MARKET DYNAMICS

The Antibodies market is expected to grow significantly in the coming years, owing to the key factors such as rising volume of collaborations between various industrial and academic organizations also enhances the growth of this market and prevalence of chronic disorders. The developing regions are likely to serve more growth opportunities in coming years due to the rising incidences of infectious diseases.

MARKET SCOPE

The "Global Antibodies Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antibodies market with detailed market segmentation by type, technology, application, end user and geography. The global Antibodies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Antibodies market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Antibodies market is segmented on the basis of type, technology, application and end user. On the basis of type, the market is segmented into Monoclonal Antibodies, Polyclonal Antibodies, ADCs, Others. Based on the technology the market is divided into Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Others. On the basis of application, the market is segmented into Proteomics, Drug Development, Genomics. On the basis of end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs

Get more information on this report :


 
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Antibodies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antibodies marke tby each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antibodies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antibodies market in these regions.

Get more information on this report :


 
MARKET PLAYERS

The reports cover key developments in the Antibodies marketas organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Antibodies marketare anticipated to lucrative growth opportunities in the future with the rising demand for Antibodies marketin the global market. Below mentioned is the list of few companies engaged in the bioanalytical testing services market.

The report also includes the profiles of key Antibodies marketcompanies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  • Merck KGaAB
  • Cell Signaling Technology , Inc
  • BD
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies , Inc
  • Beckman Coulter, Inc.
  • GenScript.
  • QIAGEN
  • Affinity Biologicals, Inc.


The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :


 

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Antibodies Market - By Type
 1.3.2 Antibodies Market - By Technology
 1.3.3 Antibodies Market - By Application
 1.3.4 Antibodies Market - By End-User
 1.3.5 Antibodies Market - By Region
 1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTIBODIES MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS

5. ANTIBODIES MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. ANTIBODIES MARKET - GLOBAL MARKET ANALYSIS
 6.1. ANTIBODIES - GLOBAL MARKET OVERVIEW
 6.2. ANTIBODIES - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE

7. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
 7.1. OVERVIEW
 7.2. TYPE MARKET FORECASTS AND ANALYSIS
 7.3. MONOCLONAL ANTIBODIES
 7.3.1. Overview
 7.3.2. Monoclonal Antibodies Market Forecast and Analysis
 7.4. POLYCLONAL ANTIBODIES
 7.4.1. Overview
 7.4.2. Polyclonal Antibodies Market Forecast and Analysis
 7.5. ADCS
 7.5.1. Overview
 7.5.2. ADCs Market Forecast and Analysis
 7.6. OTHERS
 7.6.1. Overview
 7.6.2. Others Market Forecast and Analysis

8. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
 8.1. OVERVIEW
 8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
 8.3. WESTERN BLOTTING
 8.3.1. Overview
 8.3.2. Western Blotting Market Forecast and Analysis
 8.4. FLOW CYTOMETRY
 8.4.1. Overview
 8.4.2. Flow Cytometry Market Forecast and Analysis
 8.5. ELISA
 8.5.1. Overview
 8.5.2. ELISA Market Forecast and Analysis
 8.6. IMMUNOHISTOCHEMISTRY
 8.6.1. Overview
 8.6.2. Immunohistochemistry Market Forecast and Analysis
 8.7. IMMUNOFLUORESCENCE
 8.7.1. Overview
 8.7.2. Immunofluorescence Market Forecast and Analysis
 8.8. IMMUNOPRECIPITATION
 8.8.1. Overview
 8.8.2. Immunoprecipitation Market Forecast and Analysis
 8.9. OTHERS
 8.9.1. Overview
 8.9.2. Others Market Forecast and Analysis

9. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
 9.1. OVERVIEW
 9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
 9.3. INTO PROTEOMICS
 9.3.1. Overview
 9.3.2. into Proteomics Market Forecast and Analysis
 9.4. DRUG DEVELOPMENT
 9.4.1. Overview
 9.4.2. Drug Development Market Forecast and Analysis
 9.5. GENOMICS
 9.5.1. Overview
 9.5.2. Genomics Market Forecast and Analysis

10. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
 10.1. OVERVIEW
 10.2. END-USER MARKET FORECASTS AND ANALYSIS
 10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
 10.3.1. Overview
 10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
 10.4. ACADEMIC AND RESEARCH INSTITUTES,
 10.4.1. Overview
 10.4.2. Academic and Research Institutes, Market Forecast and Analysis
 10.5. CROS
 10.5.1. Overview
 10.5.2. CROs Market Forecast and Analysis

11. ANTIBODIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 11.1. NORTH AMERICA
 11.1.1 North America Antibodies Market Overview
 11.1.2 North America Antibodies Market Forecasts and Analysis
 11.1.3 North America Antibodies Market Forecasts and Analysis - By Type
 11.1.4 North America Antibodies Market Forecasts and Analysis - By Technology
 11.1.5 North America Antibodies Market Forecasts and Analysis - By Application
 11.1.6 North America Antibodies Market Forecasts and Analysis - By End-User
 11.1.7 North America Antibodies Market Forecasts and Analysis - By Countries
 11.1.7.1 United States Antibodies Market
 11.1.7.1.1 United States Antibodies Market by Type
 11.1.7.1.2 United States Antibodies Market by Technology
 11.1.7.1.3 United States Antibodies Market by Application
 11.1.7.1.4 United States Antibodies Market by End-User
 11.1.7.2 Canada Antibodies Market
 11.1.7.2.1 Canada Antibodies Market by Type
 11.1.7.2.2 Canada Antibodies Market by Technology
 11.1.7.2.3 Canada Antibodies Market by Application
 11.1.7.2.4 Canada Antibodies Market by End-User
 11.1.7.3 Mexico Antibodies Market
 11.1.7.3.1 Mexico Antibodies Market by Type
 11.1.7.3.2 Mexico Antibodies Market by Technology
 11.1.7.3.3 Mexico Antibodies Market by Application
 11.1.7.3.4 Mexico Antibodies Market by End-User
 11.2. EUROPE
 11.2.1 Europe Antibodies Market Overview
 11.2.2 Europe Antibodies Market Forecasts and Analysis
 11.2.3 Europe Antibodies Market Forecasts and Analysis - By Type
 11.2.4 Europe Antibodies Market Forecasts and Analysis - By Technology
 11.2.5 Europe Antibodies Market Forecasts and Analysis - By Application
 11.2.6 Europe Antibodies Market Forecasts and Analysis - By End-User
 11.2.7 Europe Antibodies Market Forecasts and Analysis - By Countries
 11.2.7.1 Germany Antibodies Market
 11.2.7.1.1 Germany Antibodies Market by Type
 11.2.7.1.2 Germany Antibodies Market by Technology
 11.2.7.1.3 Germany Antibodies Market by Application
 11.2.7.1.4 Germany Antibodies Market by End-User
 11.2.7.2 France Antibodies Market
 11.2.7.2.1 France Antibodies Market by Type
 11.2.7.2.2 France Antibodies Market by Technology
 11.2.7.2.3 France Antibodies Market by Application
 11.2.7.2.4 France Antibodies Market by End-User
 11.2.7.3 Italy Antibodies Market
 11.2.7.3.1 Italy Antibodies Market by Type
 11.2.7.3.2 Italy Antibodies Market by Technology
 11.2.7.3.3 Italy Antibodies Market by Application
 11.2.7.3.4 Italy Antibodies Market by End-User
 11.2.7.4 Spain Antibodies Market
 11.2.7.4.1 Spain Antibodies Market by Type
 11.2.7.4.2 Spain Antibodies Market by Technology
 11.2.7.4.3 Spain Antibodies Market by Application
 11.2.7.4.4 Spain Antibodies Market by End-User
 11.2.7.5 United Kingdom Antibodies Market
 11.2.7.5.1 United Kingdom Antibodies Market by Type
 11.2.7.5.2 United Kingdom Antibodies Market by Technology
 11.2.7.5.3 United Kingdom Antibodies Market by Application
 11.2.7.5.4 United Kingdom Antibodies Market by End-User
 11.3. ASIA-PACIFIC
 11.3.1 Asia-Pacific Antibodies Market Overview
 11.3.2 Asia-Pacific Antibodies Market Forecasts and Analysis
 11.3.3 Asia-Pacific Antibodies Market Forecasts and Analysis - By Type
 11.3.4 Asia-Pacific Antibodies Market Forecasts and Analysis - By Technology
 11.3.5 Asia-Pacific Antibodies Market Forecasts and Analysis - By Application
 11.3.6 Asia-Pacific Antibodies Market Forecasts and Analysis - By End-User
 11.3.7 Asia-Pacific Antibodies Market Forecasts and Analysis - By Countries
 11.3.7.1 Australia Antibodies Market
 11.3.7.1.1 Australia Antibodies Market by Type
 11.3.7.1.2 Australia Antibodies Market by Technology
 11.3.7.1.3 Australia Antibodies Market by Application
 11.3.7.1.4 Australia Antibodies Market by End-User
 11.3.7.2 China Antibodies Market
 11.3.7.2.1 China Antibodies Market by Type
 11.3.7.2.2 China Antibodies Market by Technology
 11.3.7.2.3 China Antibodies Market by Application
 11.3.7.2.4 China Antibodies Market by End-User
 11.3.7.3 India Antibodies Market
 11.3.7.3.1 India Antibodies Market by Type
 11.3.7.3.2 India Antibodies Market by Technology
 11.3.7.3.3 India Antibodies Market by Application
 11.3.7.3.4 India Antibodies Market by End-User
 11.3.7.4 Japan Antibodies Market
 11.3.7.4.1 Japan Antibodies Market by Type
 11.3.7.4.2 Japan Antibodies Market by Technology
 11.3.7.4.3 Japan Antibodies Market by Application
 11.3.7.4.4 Japan Antibodies Market by End-User
 11.3.7.5 South Korea Antibodies Market
 11.3.7.5.1 South Korea Antibodies Market by Type
 11.3.7.5.2 South Korea Antibodies Market by Technology
 11.3.7.5.3 South Korea Antibodies Market by Application
 11.3.7.5.4 South Korea Antibodies Market by End-User
 11.4. MIDDLE EAST AND AFRICA
 11.4.1 Middle East and Africa Antibodies Market Overview
 11.4.2 Middle East and Africa Antibodies Market Forecasts and Analysis
 11.4.3 Middle East and Africa Antibodies Market Forecasts and Analysis - By Type
 11.4.4 Middle East and Africa Antibodies Market Forecasts and Analysis - By Technology
 11.4.5 Middle East and Africa Antibodies Market Forecasts and Analysis - By Application
 11.4.6 Middle East and Africa Antibodies Market Forecasts and Analysis - By End-User
 11.4.7 Middle East and Africa Antibodies Market Forecasts and Analysis - By Countries
 11.4.7.1 South Africa Antibodies Market
 11.4.7.1.1 South Africa Antibodies Market by Type
 11.4.7.1.2 South Africa Antibodies Market by Technology
 11.4.7.1.3 South Africa Antibodies Market by Application
 11.4.7.1.4 South Africa Antibodies Market by End-User
 11.4.7.2 Saudi Arabia Antibodies Market
 11.4.7.2.1 Saudi Arabia Antibodies Market by Type
 11.4.7.2.2 Saudi Arabia Antibodies Market by Technology
 11.4.7.2.3 Saudi Arabia Antibodies Market by Application
 11.4.7.2.4 Saudi Arabia Antibodies Market by End-User
 11.4.7.3 U.A.E Antibodies Market
 11.4.7.3.1 U.A.E Antibodies Market by Type
 11.4.7.3.2 U.A.E Antibodies Market by Technology
 11.4.7.3.3 U.A.E Antibodies Market by Application
 11.4.7.3.4 U.A.E Antibodies Market by End-User
 11.5. SOUTH AND CENTRAL AMERICA
 11.5.1 South and Central America Antibodies Market Overview
 11.5.2 South and Central America Antibodies Market Forecasts and Analysis
 11.5.3 South and Central America Antibodies Market Forecasts and Analysis - By Type
 11.5.4 South and Central America Antibodies Market Forecasts and Analysis - By Technology
 11.5.5 South and Central America Antibodies Market Forecasts and Analysis - By Application
 11.5.6 South and Central America Antibodies Market Forecasts and Analysis - By End-User
 11.5.7 South and Central America Antibodies Market Forecasts and Analysis - By Countries
 11.5.7.1 Brazil Antibodies Market
 11.5.7.1.1 Brazil Antibodies Market by Type
 11.5.7.1.2 Brazil Antibodies Market by Technology
 11.5.7.1.3 Brazil Antibodies Market by Application
 11.5.7.1.4 Brazil Antibodies Market by End-User
 11.5.7.2 Argentina Antibodies Market
 11.5.7.2.1 Argentina Antibodies Market by Type
 11.5.7.2.2 Argentina Antibodies Market by Technology
 11.5.7.2.3 Argentina Antibodies Market by Application
 11.5.7.2.4 Argentina Antibodies Market by End-User

12. INDUSTRY LANDSCAPE
 12.1. MERGERS AND ACQUISITIONS
 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 12.3. NEW PRODUCT LAUNCHES
 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. ANTIBODIES MARKET, KEY COMPANY PROFILES
 13.1. MERCK KGAAB
 13.1.1. Key Facts
 13.1.2. Business Description
 13.1.3. Products and Services
 13.1.4. Financial Overview
 13.1.5. SWOT Analysis
 13.1.6. Key Developments
 13.2. CELL SIGNALING TECHNOLOGY , INC
 13.2.1. Key Facts
 13.2.2. Business Description
 13.2.3. Products and Services
 13.2.4. Financial Overview
 13.2.5. SWOT Analysis
 13.2.6. Key Developments
 13.3. BD
 13.3.1. Key Facts
 13.3.2. Business Description
 13.3.3. Products and Services
 13.3.4. Financial Overview
 13.3.5. SWOT Analysis
 13.3.6. Key Developments
 13.4. F. HOFFMANN-LA ROCHE LTD
 13.4.1. Key Facts
 13.4.2. Business Description
 13.4.3. Products and Services
 13.4.4. Financial Overview
 13.4.5. SWOT Analysis
 13.4.6. Key Developments
 13.5. BIO-RAD LABORATORIES INC.
 13.5.1. Key Facts
 13.5.2. Business Description
 13.5.3. Products and Services
 13.5.4. Financial Overview
 13.5.5. SWOT Analysis
 13.5.6. Key Developments
 13.6. AGILENT TECHNOLOGIES , INC
 13.6.1. Key Facts
 13.6.2. Business Description
 13.6.3. Products and Services
 13.6.4. Financial Overview
 13.6.5. SWOT Analysis
 13.6.6. Key Developments
 13.7. BECKMAN COULTER, INC.
 13.7.1. Key Facts
 13.7.2. Business Description
 13.7.3. Products and Services
 13.7.4. Financial Overview
 13.7.5. SWOT Analysis
 13.7.6. Key Developments
 13.8. GENSCRIPT.
 13.8.1. Key Facts
 13.8.2. Business Description
 13.8.3. Products and Services
 13.8.4. Financial Overview
 13.8.5. SWOT Analysis
 13.8.6. Key Developments
 13.9. QIAGEN
 13.9.1. Key Facts
 13.9.2. Business Description
 13.9.3. Products and Services
 13.9.4. Financial Overview
 13.9.5. SWOT Analysis
 13.9.6. Key Developments
 13.10. AFFINITY BIOLOGICALS, INC
 13.10.1. Key Facts
 13.10.2. Business Description
 13.10.3. Products and Services
 13.10.4. Financial Overview
 13.10.5. SWOT Analysis
 13.10.6. Key Developments

14. APPENDIX
 14.1. ABOUT THE INSIGHT PARTNERS
 14.2. GLOSSARY OF TERMS

 

The List of Companies

1. Merck KGaAB
2. Cell Signaling Technology , Inc
3. BD
4. F. Hoffmann-La Roche Ltd
5. Bio-Rad Laboratories Inc.
6. Agilent Technologies , Inc
7. Beckman Coulter, Inc.
8. GenScript.
9. QIAGEN
10. Affinity Biologicals, Inc.

 

TIPRE00005787
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking